Filing Details

Accession Number:
0001209191-17-023841
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-31 16:09:09
Reporting Period:
2017-03-29
Filing Date:
2017-03-31
Accepted Time:
2017-03-31 16:09:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1406338 Amit Sachdev C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp, Cro No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-29 5,719 $38.80 105,054 No 4 M Direct
Common Stock Acquisiton 2017-03-29 17,156 $37.86 122,210 No 4 M Direct
Common Stock Acquisiton 2017-03-29 29,032 $48.74 151,242 No 4 M Direct
Common Stock Acquisiton 2017-03-29 28,593 $45.11 179,835 No 4 M Direct
Common Stock Disposition 2017-03-29 51,468 $106.30 128,367 No 4 S Direct
Common Stock Disposition 2017-03-29 29,032 $110.00 99,335 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2017-03-29 5,719 $38.80 5,719 $38.80
Common Stock Stock Option (Right to Buy) Disposition 2017-03-29 17,156 $37.86 17,156 $37.86
Common Stock Stock Option (Right to Buy) Disposition 2017-03-29 29,032 $48.74 29,032 $48.74
Common Stock Stock Option (Right to Buy) Disposition 2017-03-29 28,593 $45.11 28,593 $45.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-02-02 No 4 M Direct
0 2022-02-01 No 4 M Direct
0 2022-07-24 No 4 M Direct
0 2023-02-04 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 882 Indirect 401k
Footnotes
  1. Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
  2. Fully vested.